Liver Fibrosis and the Risks of Impaired Cognition and Dementia: Mechanisms, Evidence, and Clinical Implications — Mohamad Jamalinia (2025) | RDL Network
Liver fibrosis, the progressive accumulation of scar tissue resulting from chronic liver disease, is increasingly recognized as a multi-system condition whose effects transcend the liver, affecting brain health. In parallel, dementia determining progressively impaired cognition severe enough to impede daily functioning, is a significant global health issue whose risk factors and pathogenic precursors are incompletely defined. Increasing evidence suggests that certain pathophysiological correlates of chronic liver disease may negatively affect neuronal health through incompletely defined pathophysiological mechanisms. With this background, we appraise our current understanding of the relationship between liver fibrosis and cognitive impairment/dementia, using a variety of different methodologies. Firstly, the pathophysiology and clinical significance of liver fibrosis are discussed. Next, we describe the various types of dementia and related risk factors. We then present research evidence supporting the association between cognitive impairment/dementia and liver fibrosis. We highlight both consistency and heterogeneity of findings, including the degree of association being affected by liver fibrosis severity. We thoroughly examine potential causal mechanisms, comprising the role of chronic systemic and neuroinflammation, insulin resistance, vascular dysfunction, and intestinal microbiota-liver-brain axis as potential connectors of liver health with cognitive impairment and dementia. We briefly analyze how sex and age may modify the above associations, how liver fibrosis and cognitive function should be diagnosed, and those potential preventive/treatment strategies based on the shared metabolic/inflammatory pathways associating liver fibrosis, cognitive impairment and dementia. Finally, major research gaps are identified, together with matching proposals for prioritizing advancements in our understanding of the increasingly identified connections between liver fibrosis and dementia/cognitive impairment.
Boris Bikbov, María José Soler, Vesna Pešić, Giovambattista Capasso, Robert J. Unwin, Matthias Endres, Giuseppe Remuzzi, Norberto Perico, Ron T. Gansevoort, Francesco Mattace‐Raso, Annette Bruchfeld, Andreja Figurek, Gaye Hafez, Giovambattista Capasso, Alexandre Andrade, Maie Bachmann, Inga Arūnė Bumblytė, Adrian Covic, Pilar Delgado, Nicole Endlich, Andreas Engvig, Denis Fouque, Casper Franssen, Sebastian Frische, Liliana Garneata, Loreto Gesualdo, Konstantinos Giannakou, Dimitrios Goumenos, Ayşe Tuğba Kartal, Laila-Yasmin Mani, Hans-Peter Marti, Christopher Mayer, Rikke Nielsen, Merita Rroji, Giorgos K. Sakkas, Goce Spasovski, Kate Stevens, Evgueniy Vazelov, Davide Viggiano, Lefteris Zacharia, Ana Carina Ferreira, Jolanta Małyszko, Ewout J. Hoorn, Andreja Figurek, Robert J. Unwin, Carsten A. Wagner, Christoph Wanner, Marion Pépin, Andrzej Więcek, Dorothea Nitsch, Ivo Fridolin, Gaye Hafez, María José Soler Romeo, Michelangela Barbieri, Bojan Batinić, Laura Carrasco, Sol Carriazo, Ron T. Gansevoort, Gianvito Martino, Francesco Mattace‐Raso, Ionuţ Nistor, Alberto Ortíz, Giuseppe Paolisso, Daiva Rastenytė, Gabriel Ştefan, Gioacchino Tedeschi, Ziad A. Massy, Boris Bikbov, Karlhans Endlich, Olivier Godefroy, Jean‐Marc Chillon, Anastassia Kossioni, Justina Kurganaite, Giuseppe Remuzzi, Tomasz Grodzicki, Francesco Trepiccione, Carmine Zoccali, Mustafa Arıcı, Peter J. Blankestijn, Kai‐Uwe Eckardt, Danilo Fliser, Eugenio Gutiérrez Jiménez, Maximilian König, Ivan Rychlik, Michela Deleidi, György Reusz
Jun Li, Ana W. Capuano, Puja Agarwal, Zoe Arvanitakis, Yanling Wang, Philip L. De Jager, Julie A. Schneider, Shinya Tasaki, Kátia de Paiva Lopes, Frank B Hu, David A. Bennett, Liming Liang, Francine Grodstein
Discussion(0)
No comments yet. Be the first to comment.